scispace - formally typeset
W

Winnie Wong

Researcher at University of Alberta

Publications -  25
Citations -  1401

Winnie Wong is an academic researcher from University of Alberta. The author has contributed to research in topics: Liver transplantation & Immunosuppression. The author has an hindex of 16, co-authored 24 publications receiving 1343 citations.

Papers
More filters
Journal ArticleDOI

Sirolimus‐based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

TL;DR: The Milan criteria for liver transplantation in the presence of HCC can be carefully extended without compromising outcomes and this sirolimus based immunosuppression protocol appears to have beneficial effects on tumor recurrence and survival with an acceptable rate of rejection and toxicity.
Journal ArticleDOI

Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery

TL;DR: Results demonstrated that codelivery of HBcAg and MPLA in PLGA nanoparticles promotedHBcAg-specific Th1 immune responses with IFN-gamma production, suggesting that appropriate design of the vaccine formulation and careful planning of the immunization schedule are important in the successful development of effective HBV therapeutic vaccines.
Journal ArticleDOI

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

TL;DR: De novo sirolimus-based immunosuppression is associated with satisfactory outcomes after transplantation, even in selected patients beyond Milan criteria, and the protocol has proven safe, with an acceptable side-effect profile.
Journal ArticleDOI

Management of chronic hepatitis C: Consensus guidelines

TL;DR: The present document reviews the epidemiology of hepatitis C in Canada, treatment of acute hepatitis C and new algorithms in chronic hepatitis C, including retreatment of previous treatment failures and the use of hematopoietic growth factors to help manage patients on therapy.
Journal ArticleDOI

Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication

TL;DR: Liver sections stained for the cell division marker PCNA showed that animals in which cccDNA loss was continuous had significantly greater numbers of PCNA-positive nuclei than did those animals inWhich ccc DNA levels had plateaued, suggesting the selection of drug-resistant virus mutants is an unlikely explanation for this unexpected stabilization of cCCDNA levels.